RHHBY - ADC Therapeutics down 7% following new corporate presentation
2024-05-14 13:21:15 ET
More on ADC Therapeutics
- ADC Therapeutics: Real Opportunity With Real Risk In 2024 (Rating Upgrade)
- ADC Therapeutics gains after data for lymphoma therapy
- ADC Therapeutics SA (ADCT) Q1 2024 Earnings Call Transcript
- ADC Therapeutics SA 2024 Q1 - Results - Earnings Call Presentation
- Seeking Alpha's Quant Rating on ADC Therapeutics